Tech Company Financing Transactions

Athira Pharma Funding Round

Athira Pharma, based in Seattle, secured $85 million from Perceptive Advisors, Avidity Partners and Franklin Templeton.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series B
Proceeds Purpose
Proceeds from the financing will support a Phase 2/3 Alzheimer's clinical trial of NDX-1017. NDX-1017 is a small molecule therapeutic designed to enhance the activity of a naturally occurring repair mechanism that has the potential to restore neuronal health and brain function.

Company Information

Company Status
Mailing Address
4000 Mason Rd. 300 Box 352141
Seattle, WA 98195
Email Address
Athira Pharma (Nasdaq: ATHA) is a drug development company striving to improve human health by advancing new therapies for neurodegenerative diseases like Alzheimer's and Parkinson's. Our innovative approach is focused on turning brain degeneration into regeneration, achieved by re-establishing lost connections and restoring lost function.
Athira Pharma LinkedIn Company Profile
Social Media
Athira Pharma Company Twitter Account
Company News
Athira Pharma News
Athira Pharma on Facebook
Athira Pharma on YouTube

Management Team

Email & Social
Chief Executive Officer
Leen Kawas
  Leen Kawas LinkedIn Profile  Leen Kawas Twitter Account  Leen Kawas News  Leen Kawas on Facebook
Chief Financial Officer
Glenna Mileson
  Glenna Mileson LinkedIn Profile  Glenna Mileson Twitter Account  Glenna Mileson News  Glenna Mileson on Facebook
Chief Operating Officer
Mark Litton
  Mark Litton LinkedIn Profile  Mark Litton Twitter Account  Mark Litton News  Mark Litton on Facebook
VP - Bus. Development
Josh Pan
  Josh Pan LinkedIn Profile  Josh Pan Twitter Account  Josh Pan News  Josh Pan on Facebook
VP - General Counsel
Christina Thomson
  Christina Thomson LinkedIn Profile  Christina Thomson Twitter Account  Christina Thomson News  Christina Thomson on Facebook
VP - R & D
Xue Hua
  Xue Hua LinkedIn Profile  Xue Hua Twitter Account  Xue Hua News  Xue Hua on Facebook



Browse more venture capital transactions:

Prev: 6/4/2020: BetterView venture capital transaction
Next: 6/5/2020: Routinify venture capital transaction


Share this article


About Our Venture Capital Transactions Database

We do our best to document every notable VC transaction. VC investment data records reported here are derived from a variety of public sources. The information comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary